JPH0253717A - Dentifrice or mouth wash - Google Patents
Dentifrice or mouth washInfo
- Publication number
- JPH0253717A JPH0253717A JP63205392A JP20539288A JPH0253717A JP H0253717 A JPH0253717 A JP H0253717A JP 63205392 A JP63205392 A JP 63205392A JP 20539288 A JP20539288 A JP 20539288A JP H0253717 A JPH0253717 A JP H0253717A
- Authority
- JP
- Japan
- Prior art keywords
- extract
- plant
- dentifrice
- camellia
- jiyu
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000002324 mouth wash Substances 0.000 title claims abstract description 17
- 229940051866 mouthwash Drugs 0.000 title claims abstract description 15
- 239000000551 dentifrice Substances 0.000 title abstract description 5
- 239000000284 extract Substances 0.000 claims abstract description 31
- 244000269722 Thea sinensis Species 0.000 claims abstract description 21
- 241000196324 Embryophyta Species 0.000 claims abstract description 13
- 239000000843 powder Substances 0.000 claims abstract description 12
- 235000006468 Thea sinensis Nutrition 0.000 claims abstract description 11
- 235000020279 black tea Nutrition 0.000 claims abstract description 11
- 235000018597 common camellia Nutrition 0.000 claims abstract description 11
- 235000009569 green tea Nutrition 0.000 claims abstract description 7
- 239000000606 toothpaste Substances 0.000 claims description 19
- 229940034610 toothpaste Drugs 0.000 claims description 18
- 240000001548 Camellia japonica Species 0.000 claims description 7
- 244000080767 Areca catechu Species 0.000 claims description 4
- 235000006226 Areca catechu Nutrition 0.000 claims description 4
- 235000005733 Raphanus sativus var niger Nutrition 0.000 claims 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 claims 1
- 240000001970 Raphanus sativus var. sativus Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 9
- 208000028169 periodontal disease Diseases 0.000 abstract description 9
- 102000004190 Enzymes Human genes 0.000 abstract description 7
- 108090000790 Enzymes Proteins 0.000 abstract description 7
- 229940088598 enzyme Drugs 0.000 abstract description 7
- 235000013399 edible fruits Nutrition 0.000 abstract description 6
- 235000004789 Rosa xanthina Nutrition 0.000 abstract description 5
- 241000220222 Rosaceae Species 0.000 abstract description 5
- 241000209507 Camellia Species 0.000 abstract description 4
- 108010003272 Hyaluronate lyase Proteins 0.000 abstract description 4
- 238000000605 extraction Methods 0.000 abstract description 4
- 230000002401 inhibitory effect Effects 0.000 abstract description 4
- 102000001974 Hyaluronidases Human genes 0.000 abstract description 3
- 206010061218 Inflammation Diseases 0.000 abstract description 3
- 229960002773 hyaluronidase Drugs 0.000 abstract description 3
- 230000004054 inflammatory process Effects 0.000 abstract description 3
- 239000003906 humectant Substances 0.000 abstract description 2
- 239000003755 preservative agent Substances 0.000 abstract description 2
- 230000003449 preventive effect Effects 0.000 abstract description 2
- 239000004094 surface-active agent Substances 0.000 abstract description 2
- 241000758706 Piperaceae Species 0.000 abstract 1
- 244000050053 Rosa multiflora Species 0.000 abstract 1
- 235000000656 Rosa multiflora Nutrition 0.000 abstract 1
- 241000581682 Sanguisorba Species 0.000 abstract 1
- 244000173853 Sanguisorba officinalis Species 0.000 abstract 1
- 235000008282 Sanguisorba officinalis Nutrition 0.000 abstract 1
- 235000011869 dried fruits Nutrition 0.000 abstract 1
- 230000000793 phophlogistic effect Effects 0.000 abstract 1
- 230000002335 preservative effect Effects 0.000 abstract 1
- 239000000419 plant extract Substances 0.000 description 15
- 239000000243 solution Substances 0.000 description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 13
- 235000019441 ethanol Nutrition 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 6
- 240000008154 Piper betle Species 0.000 description 6
- 235000008180 Piper betle Nutrition 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 241000283986 Lepus Species 0.000 description 4
- 229940094952 green tea extract Drugs 0.000 description 4
- 235000020688 green tea extract Nutrition 0.000 description 4
- 229920001503 Glucan Polymers 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 208000007565 gingivitis Diseases 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000008363 phosphate buffer Substances 0.000 description 3
- 230000002265 prevention Effects 0.000 description 3
- 235000013616 tea Nutrition 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 238000007792 addition Methods 0.000 description 2
- 230000001580 bacterial effect Effects 0.000 description 2
- 235000019437 butane-1,3-diol Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000000981 epithelium Anatomy 0.000 description 2
- 230000002779 inactivation Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 201000001245 periodontitis Diseases 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 2
- 229940081974 saccharin Drugs 0.000 description 2
- 235000019204 saccharin Nutrition 0.000 description 2
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- 240000007524 Camellia sinensis var. sinensis Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 208000002064 Dental Plaque Diseases 0.000 description 1
- 239000004375 Dextrin Substances 0.000 description 1
- 229920001353 Dextrin Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 102000000340 Glucosyltransferases Human genes 0.000 description 1
- 108010055629 Glucosyltransferases Proteins 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 241000721662 Juniperus Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- -1 Polyoxyethylene Polymers 0.000 description 1
- 241000206609 Porphyra Species 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 241000194019 Streptococcus mutans Species 0.000 description 1
- 239000003082 abrasive agent Substances 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000001070 adhesive effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000000043 antiallergic agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- ONTQJDKFANPPKK-UHFFFAOYSA-L chembl3185981 Chemical compound [Na+].[Na+].CC1=CC(C)=C(S([O-])(=O)=O)C=C1N=NC1=CC(S([O-])(=O)=O)=C(C=CC=C2)C2=C1O ONTQJDKFANPPKK-UHFFFAOYSA-L 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 210000003298 dental enamel Anatomy 0.000 description 1
- 235000019425 dextrin Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 229940095079 dicalcium phosphate anhydrous Drugs 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 229960001340 histamine Drugs 0.000 description 1
- 210000003630 histaminocyte Anatomy 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000000415 inactivating effect Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 239000011259 mixed solution Substances 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 230000007505 plaque formation Effects 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002250 progressing effect Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 229960004063 propylene glycol Drugs 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- ZWDBCMVZIKKOCJ-UHFFFAOYSA-M sodium dodecyl sulfate propane-1,2-diol Chemical compound [Na+].CC(O)CO.CCCCCCCCCCCCOS([O-])(=O)=O ZWDBCMVZIKKOCJ-UHFFFAOYSA-M 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- 235000013599 spices Nutrition 0.000 description 1
- 230000006641 stabilisation Effects 0.000 description 1
- 238000011105 stabilization Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 230000001960 triggered effect Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
【発明の詳細な説明】
[産業上の利用分野]
本発明は起炎酵素とも呼ばれ、炎症発生に関与するヒア
ルロニダーゼ(以下Haseと略記する。)の活性を阻
害する効果をもつ植物抽出物および/またはこれら植物
の粉末を配合したことを特徴とする歯周疾患の予防、治
療効果のある歯磨または洗口料に関するものである。Detailed Description of the Invention [Industrial Application Field] The present invention provides plant extracts and plant extracts that have the effect of inhibiting the activity of hyaluronidase (hereinafter abbreviated as Hase), which is also called a inflammatory enzyme and is involved in the development of inflammation. The present invention relates to a toothpaste or mouthwash that is effective in preventing and treating periodontal diseases and is characterized by containing powders of these plants.
[従来の技術及び発明が解決しようとする課題]ムシ歯
の発生メカニズムは、まず口腔内の細菌とくにストレプ
トコッカス ミュータンスが食物由来のm糖を粘着性の
強い多糖類グルカンに変え、これが歯の表面に付着して
歯垢を形成する。ついでこの歯垢内で細菌が乳酸等の有
機酸を生産し、歯のエナメル質を脱灰させることにある
とされている。[Prior art and problems to be solved by the invention] The mechanism by which dental caries occurs is that bacteria in the oral cavity, especially Streptococcus mutans, convert food-derived m-saccharide into a highly adhesive polysaccharide glucan, which is then transferred to the tooth surface. It adheres to the teeth and forms plaque. Bacteria then produce organic acids such as lactic acid within this plaque, which is believed to demineralize tooth enamel.
このムシ歯の発生プロセスに基づいて、ストレプトコッ
カス ミニ−タンス対策として殺菌剤が、グルカン生成
に関与する酵素グルコシルトランスフェラーゼ対策とし
て抗酵素剤が、またグルカン生成阻害あるいは歯面への
付着阻止対策として酵素デキストラナーゼが応用されて
いる。Based on this process of dental caries development, bactericidal agents are used to prevent Streptococcus minitans, antienzyme agents are used to prevent glucosyltransferase, an enzyme involved in glucan production, and enzyme dextrin is used to inhibit glucan production or prevent adhesion to tooth surfaces. Stranase has been applied.
他方、歯槽膿漏、歯肉炎等のいわゆる歯周疾患について
は、最近厚生省が成人病の1つとしてその予防対策に取
組むとの見解を発表したほど重要問題になっているにか
かわらず、その原因についてはムシ歯はど究明されてい
ないのが現状である。On the other hand, so-called periodontal diseases such as alveolar pyorrhea and gingivitis have become such an important problem that the Ministry of Health and Welfare recently announced that measures will be taken to prevent them as an adult disease. Currently, the cause of dental caries has not been investigated.
本発明者等は、歯周疾患の予防、治療剤を新たな視点よ
り開発することを意図し下記のことに着目した。即ち、
■最近、アレルギーの発症は抗原−抗体反応が引金とな
って、肥満細胞内の)Iaseが活性化され、炎症のメ
ゾイエイタ−であるヒスタミンが過剰に遊離することに
基因することが明らかにされ、抗炎症剤、抗アレルギー
剤の創製がHase阻害剤の観点から進められているこ
と、■歯垢に含まれる細菌群の菌体外酵素Ba5eが歯
ぐき上皮の滲透性を増し、歯肉炎が発症すること、およ
び■歯ぐき上皮の細胞を接着させている物質、即ちセメ
ント物質に含まれるヒアルロン酸がBa5eによって分
解されζ細胞間隙の拡大−細菌の増殖、歯垢の形成によ
る刺激のプロセスで歯肉炎が発症することに着目した。The present inventors focused on the following with the intention of developing preventive and therapeutic agents for periodontal diseases from a new perspective. That is,
■Recently, it has been revealed that the onset of allergies is triggered by an antigen-antibody reaction, which activates Iase in mast cells and releases excessive histamine, which is a mesoieator of inflammation. , the creation of anti-inflammatory agents and anti-allergic agents is progressing from the perspective of Hase inhibitors; ■ Extracellular enzyme Ba5e of the bacterial group contained in dental plaque increases the permeability of the gum epithelium, leading to the development of gingivitis. and ■ Hyaluronic acid contained in cement, the substance that adheres the cells of the gum epithelium, is decomposed by Ba5e and the ζ cell gap expands - a process stimulated by bacterial proliferation and plaque formation, leading to gingivitis. We focused on the occurrence of
本発明者等は上記の観点に基づき、Haseの阻害剤を
新しい分野に求めて研究を重ねた結果、他の用途に利用
されてきた植物の抽出物にHaseを阻害するものが存
在することを見出し本発明を完成した。Based on the above viewpoint, the present inventors conducted repeated research in search of Hase inhibitors in a new field, and as a result, they discovered that there are substances that inhibit Hase in plant extracts that have been used for other purposes. Heading The invention has been completed.
即ち、本発明の目的は、)lassを阻害する作用を持
つ植物抽出物を配合した歯磨または洗口料を提供し、歯
周疾患の予防、治療に資することにある。That is, an object of the present invention is to provide a toothpaste or mouthwash containing a plant extract having the effect of inhibiting periodontal diseases, thereby contributing to the prevention and treatment of periodontal diseases.
なお、本発明の植物抽出物の内ジユ、エイジツ抽出物に
は収れん作用が、またジユ抽出物に抗菌作用のあること
が分かつており、この面でも歯周疾患の予防、治療に好
適である。In addition, it has been found that among the plant extracts of the present invention, the extracts of the plant extract have an astringent effect, and the extract of the extract of the present invention has an antibacterial effect, and in this respect, they are suitable for the prevention and treatment of periodontal diseases. .
[課題を解決するための手段〕
本発明に用いる植物抽出物および/または植物の粉末は
、ジユ、エイジツ、紅茶、緑茶、ツバキおよびキンマか
ら選ばれる1f!!または2種以上を基原とするもので
ある。これらは適宜組合せて使用することができる。[Means for Solving the Problems] The plant extract and/or plant powder used in the present invention is selected from 1f! ! Or it is based on two or more types. These can be used in combination as appropriate.
なお、上記の植物抽出物とは、特に明記しない限り、後
述の方法によって得られる植物抽出液、その希釈液、そ
の濃縮エキスおよび乾燥粉末を意味するが、本発明では
これら原植物を乾燥、粉末化した原末をも使用すること
ができる。その理由は、本発明が対象とする歯磨または
洗口料には水、アルコールおよび1.3−ブチレングリ
コール、ポリエチレングリコール、グリセリン等の保湿
剤が含まれているため製造プロセス中、保存中または用
時唾液で、有効成分が抽出されるにある。In addition, unless otherwise specified, the above-mentioned plant extract means a plant extract obtained by the method described below, a diluted solution thereof, a concentrated extract thereof, and a dried powder, but in the present invention, these original plants are dried and powdered. A converted bulk powder can also be used. The reason for this is that the toothpaste or mouthrinse targeted by the present invention contains water, alcohol, and moisturizing agents such as 1,3-butylene glycol, polyethylene glycol, and glycerin, so it is difficult to use during the manufacturing process, storage, or use. The active ingredients are extracted from saliva.
本発明に用いる植物抽出物の抽出には、水、および水と
混合できるメチルアルコール、エチルアルコール、イソ
プロピルアルコール等の低級−価アルコール、プロピレ
ングリコール、1.3−ブチレングリコール、ヘキシレ
ングリコール、ポリエチレングリコール等のグリコール
類、グリセリン等の有機溶剤の1f!または2種以上を
適宜組み合わせて使用することができる。また、抽出温
度は特に限定されず、高温、室温、低温の何れでもよい
。For the extraction of the plant extract used in the present invention, water, lower-hydric alcohols such as methyl alcohol, ethyl alcohol, and isopropyl alcohol that can be mixed with water, propylene glycol, 1,3-butylene glycol, hexylene glycol, and polyethylene glycol are used. 1f of glycols such as, organic solvents such as glycerin! Alternatively, two or more types can be used in appropriate combination. Further, the extraction temperature is not particularly limited, and may be high temperature, room temperature, or low temperature.
ジユ、エイジツはいずれも古くから生薬として、またキ
ンマは香辛料として使用されているものであり、また、
紅茶、緑茶も古くから飲用に供されているものであっ°
て、その人体に対する安全性は極めて高いものである。Both jiyu and jitsu have been used as herbal medicines since ancient times, and betel nut has been used as a spice.
Black tea and green tea have also been served for drinking since ancient times.
Therefore, its safety for the human body is extremely high.
ジユは地楡であり、バラ科のワレモコウおよびその変種
の根あるいは根茎を用いることがより好ましい。Jyu is a ground elm, and it is more preferable to use the roots or rhizomes of Porphyra and its varieties, which belong to the Rosaceae family.
エイジツは営実であり、バラ科のノイバラまたはその近
縁植物の偽果または果実を用いることが好ましい。It is a commercial fruit, and it is preferable to use false fruits or fruits of Rosaceae or its related plants belonging to the Rosaceae family.
紅茶、緑茶は何れもツバキ科のチャを基原とし、前者は
醗酵処理を行ったもの、一方後者は醗酵を阻止したもの
であるがそれぞれ若葉を用いることが好ましい。またツ
バキの葉もまた同様に用いることができる。なお、チャ
とツバキは新鮮な葉も利用できる。Black tea and green tea are both based on tea of the Camellia family, and the former is fermented and the latter is fermented, but it is preferable to use young leaves of each. Additionally, camellia leaves can also be used in the same manner. In addition, fresh leaves of tea and camellia can also be used.
キンマはコシヨウ科の鉤部の果穂を乾燥して用いること
が好ましい。It is preferable to use betel by drying the hook part of the betel, which belongs to the Betelinaceae family.
本発明においては、これらの植物の抽出物あるいは粉末
を単独であるいは2種以上を混合してそのまま使用する
か、あるいは適当に製剤化して使用することができる。In the present invention, extracts or powders of these plants can be used alone or in a mixture of two or more, or can be used after being appropriately formulated.
これらを歯磨または洗口料に配合して使用すればHas
eを失活させ、歯周疾患を予防若しくは治癒することが
可能になる。If you use these in your toothpaste or mouthwash,
It becomes possible to prevent or cure periodontal disease by inactivating e.
本発明の歯磨または洗口料を製造するにあたって使用さ
れる研磨剤、保湿剤、粘結剤、界面活性剤、保存剤およ
び薬効成分等は、通常の歯磨または洗口料に使用される
ものから剤型に応じて適宜選択すればよく、特に制限さ
れるものではない。The abrasives, humectants, binders, surfactants, preservatives, medicinal ingredients, etc. used in manufacturing the toothpaste or mouthwash of the present invention are those used in ordinary toothpastes or mouthwashes. It may be appropriately selected depending on the dosage form and is not particularly limited.
本発明の歯磨または洗口料中に占める植物抽出物や粉末
の量は剤型によって異なるが、通常抽出前の原植物に換
算して約0 、003零以上であることが望ましい。The amount of the plant extract or powder in the toothpaste or mouthwash of the present invention varies depending on the dosage form, but it is usually desirable that it be about 0.003 or more when converted to the original plant before extraction.
[実 施 例] 以下、実施例によって本発明を具体的に説明する。[Example] Hereinafter, the present invention will be specifically explained with reference to Examples.
(実施例1 植物抽出物調製)
・ジユ抽出物
ワレモコウの根の細片100gを50%エチルアルコー
ル800m旦で加温抽出し冷後濾過する。濾液を減圧下
蒸発乾固し、残渣を水8001n9.に加熱溶解する。(Example 1 Preparation of Plant Extract) - Extract of 100 g of roots of C. chinensis with 800 m of 50% ethyl alcohol, cooled, and filtered. The filtrate was evaporated to dryness under reduced pressure, and the residue was dissolved in 8001 nm of water. Dissolve by heating.
玲後不溶物を濾別し、濾液を減圧濃縮する。残留物を5
0λエチルアルコールに溶解し全量を300m交に調整
した。After that, the insoluble matter is filtered off, and the filtrate is concentrated under reduced pressure. 5 residues
It was dissolved in 0λ ethyl alcohol and the total amount was adjusted to 300m.
・エイジツ抽出物
ノイバラの果実粉末100gを5096工チルアルコー
ル500mff1に加え、加熱抽出し冷後濾過する。濾
液を減圧濃縮し、残留物を50零エチルアルコールに溶
解して全量を200m1に調整した。・Add 100 g of fruit powder of Eizu extract to 500 mff1 of 5096-ethyl alcohol, heat extract, cool, and filter. The filtrate was concentrated under reduced pressure, and the residue was dissolved in 50% ethyl alcohol to adjust the total volume to 200 ml.
・紅茶抽出物
僅かに乾燥したアラサムチャの葉をよく揉み醗酵させた
のち、85〜90℃で乾燥する。この細片10gに50
零エチルアルコール100 mlを加え室温で5日間抽
出したのち冷却し濾過する。この濾Y夜に60零の1.
3−ブチレングリコール50m1を加え再度濾過した。- Black tea extract Slightly dried Arasamcha leaves are thoroughly rubbed and fermented, then dried at 85-90°C. 50 for 10g of this strip
Add 100 ml of zero ethyl alcohol and extract at room temperature for 5 days, then cool and filter. 60 zeros on this night.
50 ml of 3-butylene glycol was added and filtered again.
・緑茶抽出物
チャの若葉を水蒸気で蒸し、よく揉み乾燥する。この細
片を上記の紅茶抽出物の製法に準じて溶剤処理した。・Green tea extract Steam young tea leaves with steam, rub well and dry. The strips were treated with a solvent according to the method for producing black tea extract described above.
・ツバキ抽出物
新鮮なツバキの葉の細片を上記の紅茶抽出物の製法に準
じて溶剤処理した。- Camellia extract Fresh camellia leaf strips were treated with a solvent according to the method for producing black tea extract described above.
・キンマ抽出物
乾燥したキンマの果糖の細片10gを50%の1.3−
ブチレングリコール40gに加え室温で2日間抽出した
のち濾過した。・Betel extract 10g of dried betel fructose strips 50% 1.3-
The mixture was added to 40 g of butylene glycol, extracted at room temperature for 2 days, and then filtered.
(実施例2 植物抽出物のHa s e失活効果)Ha
seの失活効果は、HA温溶液粘度が酵素分解によって
低下する現象に基づいて、上記実施例1で得られた抽出
物と添加した系および無添加の系での粘度変化をそれぞ
れオストヮルド粘度計を用いて経時的に測定することに
よって試験した。(Example 2 Ha se inactivation effect of plant extract) Ha
The inactivation effect of se is based on the phenomenon that the viscosity of a hot solution of HA decreases due to enzymatic decomposition. It was tested by measuring over time using
(試験方法)
■ 実施例1で得られた抽出物を添加した系では、下記
の基質溶液(7mu)、酵素溶液(1社)、および抽出
物溶液(1社)からなる混合溶液の37℃における粘度
変化を経時的に測定した。他方、
■ 抽出物を添加しない系(コントロール)では、抽出
物溶液の代りにo、1モルのリン酸緩衝液(i nIN
)を加えた3成分混合液の粘度変化を上記■と同様に測
定した。(Test method) ■ In the system to which the extract obtained in Example 1 was added, a mixed solution consisting of the following substrate solution (7 mu), enzyme solution (1 company), and extract solution (1 company) was heated at 37°C. The viscosity change was measured over time. On the other hand, ■ In the system without the addition of extract (control), o, 1 molar phosphate buffer (inININ) was added instead of the extract solution.
) was added to the 3-component mixture, and the viscosity change was measured in the same manner as in (2) above.
基質溶液:ヒアルロン酸ナトリウム
(キューピー株式会社製、分子量
100〜120万)を0.1モルのリン酸緩衝液(pH
6,0)に溶解し
0.496溶液を調製した。Substrate solution: Sodium hyaluronate (manufactured by Kewpie Co., Ltd., molecular weight 1,000,000 to 1,200,000) was dissolved in 0.1 molar phosphate buffer (pH
6,0) to prepare a 0.496 solution.
・酵素溶液:牛皐丸ヒアルロニダーゼ くシグマ社製、タイプis )を 0.1モルのリン酸緩衝液(pH 6,0)に溶解し0.001%溶液を調製した。・Enzyme solution: Ushigomaru hyaluronidase (manufactured by Sigma, type is) 0.1 molar phosphate buffer (pH 6.0) to prepare a 0.001% solution.
・抽出物溶液:前記実施例1で製造した植物抽出物を0
.1モルのリン酸M衝液
(pHe、o)でジユについては30
倍、エイジツについては10倍、
紅茶、緑茶については100倍、
ツバキ、キンマについては5倍
に希釈した液。・Extract solution: 0 of the plant extract produced in Example 1 above.
.. A solution diluted with 1 molar phosphate M solution (pHe, o), diluted 30 times for juniper, 10 times for age, 100 times for black and green tea, and 5 times for camellia and betel.
それぞれの溶液の測定開始時の相対粘度を1とし、各反
応時間の相対粘度の比率を算出した。その結果を表に示
す。表中の括弧内の数字は、)(Aの安定化率、即ち、
1(aseによるl(Aの分解を制御し、安定化する効
果を表すもので、各反応時間における相対粘度をもとに
次式を用いて算出した数字である。The relative viscosity of each solution at the start of measurement was set as 1, and the ratio of relative viscosity at each reaction time was calculated. The results are shown in the table. The numbers in parentheses in the table are )(stabilization rate of A, i.e.
It represents the effect of controlling and stabilizing the decomposition of l(A) by 1(ase), and is a number calculated using the following formula based on the relative viscosity at each reaction time.
以上、数種の植物抽出物を用いた時の試験結果を例示し
た。Above, test results using several types of plant extracts have been illustrated.
(実施例3 練り歯磨) 下記の組成にて練り歯磨をへ遺した。(Example 3 toothpaste) A toothpaste was prepared with the following composition.
第2リン酸カルシウム 45.0零グリセリン
20.0 ’カルボキシメチルセルロー
ス 1.0ラウリル硫酸ナトリウム 1.8サ
ツカリン 0・1
パラオキシ安息香酸エチル 0.1
シユ抽出物(実施例1 ) 5.0紅茶粉末
2.0
フレーバー 1.5絹 製 氷
23.5(実施例4 潤
製歯磨剤)
下記の組成にて練り歯磨を製造した。Dibasic calcium phosphate 45.0 zero glycerin
20.0' Carboxymethyl cellulose 1.0 Sodium lauryl sulfate 1.8 Sacchulin 0.1 Ethyl paraoxybenzoate 0.1 Shu extract (Example 1) 5.0 Black tea powder
2.0 Flavor 1.5 Silk Ice 23.5 (Example 4 Junsei Dentifrice) A toothpaste was manufactured with the following composition.
第 2 リン酸カルシウム (2水塩)第 2 リン酸
カルシウム (無水塩)サッカリン
フレーバー
プロピレングリコール
ラウリル硫酸ナトリウム
カラギーナン
精 製 水
ツバキ抽出物(実施例1)
キンマ抽出物(実施例1)
全 量
100.0 k
(実施例5 洗口料)
下記の組成にて洗口料を製造した。Secondary calcium phosphate (dihydrate) Secondary calcium phosphate (anhydrous salt) Saccharin flavor Propylene glycol Sodium lauryl sulfate Carrageenan Purification Water camellia extract (Example 1) Betel extract (Example 1) Total amount 100.0 k (Example 1) Example 5 Mouthwash) A mouthwash was manufactured with the following composition.
エチルアルコール 20.0 *ソルビット
(aO96液) 15.0ポリオキシエチ
レン 硬化ヒマシ 油0.5エイジツ抽出物(実施例)
3.0
緑茶抽出物(実施例1)
サッカリン 0.1
フレーバー 1.0り0ルヘキシジ
ンジクルコネート 0.005精
製 氷 57.395
全 量 100.09
6上記実施例3の練り歯磨、実施例4の潤製歯磨および
実施例5の洗口料をそれぞれ軽度歯周疾患者20人に1
日3回で30日間テスト試用し、聞き取り調査を行なっ
たところ、練り歯磨および潤製歯磨の場合は20人中1
8人、洗口料の場合は20人中13人に改善傾向が見ら
れた。Ethyl alcohol 20.0 *Sorvit (aO96 liquid) 15.0 Polyoxyethylene Hydrogenated castor oil 0.5 Ajitsu extract (example)
3.0 Green Tea Extract (Example 1) Saccharin 0.1 Flavor 1.0 0 Ruhexidine Dicurconate 0.005
Ice making 57.395
Total amount 100.09
6 The toothpaste of Example 3, the moist toothpaste of Example 4, and the mouthwash of Example 5 were administered to 20 people with mild periodontal disease at 1 dose each.
After using the test three times a day for 30 days and conducting an interview survey, it was found that 1 out of 20 people found that toothpaste and Junsei toothpaste
An improvement trend was seen in 8 people, and in 13 out of 20 people who used mouthwash.
[発明の効果]
以上詳記したように、本発明は起炎酵素ヒアルロニダー
ゼの阻害作用をもつジユ、エイジツ、紅茶、緑茶、ツバ
キ、キンマの、抽出物および/またはこれらの粉末から
選ばれる1種または2種以上を配合したことを特徴とす
る歯磨または洗口料を提供するものであり、歯周炎疾患
の予防、治療に有用な歯磨または洗口料を提供するもの
であって、その効果大なるものである。[Effects of the Invention] As detailed above, the present invention provides an extract and/or a powder of betel nut, black tea, green tea, camellia, and betel nut, which has an inhibitory effect on the inflammatory enzyme hyaluronidase. The present invention provides a toothpaste or mouthwash that is characterized by containing two or more of the above, and provides a toothpaste or mouthwash that is useful for the prevention and treatment of periodontitis, and its effectiveness. It is a big thing.
手続補正書
昭和63年9月27日
1、事件の表示
昭和63年特許願
第2゜53’:2号
名(名称)
ノ【1:大/1シご紅ノ1ノし、ン1jζ刈))μ′)
)東京都千代田区丸の内2丁目6番2号丸の内へ重洲ビ
ル330補正の対象
補 正
書
本願明細書中下記事項を補正致します。Procedural Amendment September 27, 1988 1, Indication of Case 1986 Patent Application No. 2゜53': 2 Title (Name) ノ [1: Large/1 Shigo Red No. 1 No. 1, No. 1jζ Hari ))μ′)
) Shigesu Building 330, 2-6-2 Marunouchi, Chiyoda-ku, Tokyo Target of amendment The following matters in the specification of this application will be amended.
記 1、第9頁8行目に 「抽出物と添加」とあるを 「抽出物を添加」と訂正する。Record 1, page 9, line 8 It says "extracts and additions" Correct to "Add extract."
2、第13頁15行目に 「練り歯磨」とあるを 「潤製歯磨」と訂正する。2. On page 13, line 15 It says "toothpaste" I corrected it to ``Junsei Toothpaste.''
3、第14頁6行目に
[エイジツ抽出物(実施例)」とあるを[エイジツ抽出
物(実施例1)」と訂正する。3. In the 6th line of page 14, the phrase "Ajitsu extract (Example)" is corrected to "Ajitsu extract (Example 1)."
4、第14頁7行目に 「緑茶抽出物(実施例1)Jとあるを 「緑茶抽出物(実施例1) 3.OJと訂正する。4, page 14, line 7 "Green tea extract (Example 1) J" "Green tea extract (Example 1) 3. Corrected as OJ.
Claims (1)
から選ばれる1種または2種以上の植物の抽出物および
/または粉末を配合したことを特徴とする歯磨または洗
口料。1. A toothpaste or mouthwash characterized by containing extracts and/or powders of one or more plants selected from Japanese radish, black tea, green tea, camellia, and betel nut.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63205392A JPH0253717A (en) | 1988-08-18 | 1988-08-18 | Dentifrice or mouth wash |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP63205392A JPH0253717A (en) | 1988-08-18 | 1988-08-18 | Dentifrice or mouth wash |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH0253717A true JPH0253717A (en) | 1990-02-22 |
Family
ID=16506063
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP63205392A Pending JPH0253717A (en) | 1988-08-18 | 1988-08-18 | Dentifrice or mouth wash |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH0253717A (en) |
Cited By (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04273814A (en) * | 1991-02-28 | 1992-09-30 | Kanebo Ltd | Composition for oral cavity |
FR2678170A1 (en) * | 1991-06-27 | 1992-12-31 | Pacific Chem Co Ltd | ORAL COMPOSITIONS FOR THE PREVENTION OF ODONTONECROSIS AND PARADENTAL DISEASE. |
EP0727217A2 (en) * | 1995-02-10 | 1996-08-21 | Suntory Limited | Pharmaceutical composition containing god-type ellagitannin as active ingredient |
JP2006055050A (en) * | 2004-08-19 | 2006-03-02 | Lion Shoji Kk | Oral care product for animal and method for producing the same |
KR100450388B1 (en) * | 1995-11-24 | 2006-04-17 | 주식회사 엘지생활건강 | Bad breath toothpaste composition |
KR100450389B1 (en) * | 1995-11-25 | 2006-04-17 | 주식회사 엘지생활건강 | Oral liquid composition for removing bad breath |
US7238376B2 (en) | 2000-11-15 | 2007-07-03 | Rutgers, The State University | Black tea extract for prevention of disease |
WO2007133721A2 (en) * | 2006-05-12 | 2007-11-22 | Interleukin Genetics, Inc. | Food compositions and methods of treating periodontal disease |
FR2908311A1 (en) * | 2006-11-13 | 2008-05-16 | Pierre Fabre Medicament Sa | Oral hygiene composition useful for the preparation of a drug to prevent and/or treat oral dental disease and halitosis, comprises parsley essential oil and green tea extract |
JPWO2007108042A1 (en) * | 2006-03-15 | 2009-07-30 | 株式会社トロピカルテクノセンター | Anti-inflammatory agent |
CN103536482A (en) * | 2013-10-18 | 2014-01-29 | 柳州两面针股份有限公司 | Application of caulis sinomenii extract and radix sanguisorbae extract in preparing oral care product |
-
1988
- 1988-08-18 JP JP63205392A patent/JPH0253717A/en active Pending
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH04273814A (en) * | 1991-02-28 | 1992-09-30 | Kanebo Ltd | Composition for oral cavity |
FR2678170A1 (en) * | 1991-06-27 | 1992-12-31 | Pacific Chem Co Ltd | ORAL COMPOSITIONS FOR THE PREVENTION OF ODONTONECROSIS AND PARADENTAL DISEASE. |
EP0727217A2 (en) * | 1995-02-10 | 1996-08-21 | Suntory Limited | Pharmaceutical composition containing god-type ellagitannin as active ingredient |
EP0727217A3 (en) * | 1995-02-10 | 1997-01-15 | Suntory Ltd | Pharmaceutical composition containing god-type ellagitannin as active ingredient |
KR100450388B1 (en) * | 1995-11-24 | 2006-04-17 | 주식회사 엘지생활건강 | Bad breath toothpaste composition |
KR100450389B1 (en) * | 1995-11-25 | 2006-04-17 | 주식회사 엘지생활건강 | Oral liquid composition for removing bad breath |
US7238376B2 (en) | 2000-11-15 | 2007-07-03 | Rutgers, The State University | Black tea extract for prevention of disease |
JP2006055050A (en) * | 2004-08-19 | 2006-03-02 | Lion Shoji Kk | Oral care product for animal and method for producing the same |
JPWO2007108042A1 (en) * | 2006-03-15 | 2009-07-30 | 株式会社トロピカルテクノセンター | Anti-inflammatory agent |
WO2007133721A2 (en) * | 2006-05-12 | 2007-11-22 | Interleukin Genetics, Inc. | Food compositions and methods of treating periodontal disease |
WO2007133721A3 (en) * | 2006-05-12 | 2008-04-24 | Interleukin Genetics Inc | Food compositions and methods of treating periodontal disease |
FR2908311A1 (en) * | 2006-11-13 | 2008-05-16 | Pierre Fabre Medicament Sa | Oral hygiene composition useful for the preparation of a drug to prevent and/or treat oral dental disease and halitosis, comprises parsley essential oil and green tea extract |
WO2008068408A3 (en) * | 2006-11-13 | 2008-07-24 | Pf Medicament | Oral hygiene composition and its use in the treatment of halitosis |
CN103536482A (en) * | 2013-10-18 | 2014-01-29 | 柳州两面针股份有限公司 | Application of caulis sinomenii extract and radix sanguisorbae extract in preparing oral care product |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3159509B2 (en) | Protease inhibitor | |
US4952392A (en) | Use of periwinkle in oral hygiene | |
WO1992007548A1 (en) | Improved anti-plaque compositions comprising a combination of morpholinoamino alcohol and chelating agent | |
JPH0253717A (en) | Dentifrice or mouth wash | |
KR100307947B1 (en) | A method for preparation of plant extract powder and oral compositions containing plant extract powder prepared by the same | |
KR101336726B1 (en) | Composition of toothpaste which contains flower fragments | |
KR101216427B1 (en) | Calendula officinalis dentifrice composition and process for preparing the same | |
JP3685470B2 (en) | Composition for promoting oral hygiene | |
KR101703269B1 (en) | Oral care composition comprising Magnolia officinalis extract and bicarbonate | |
JP3008525B2 (en) | Oral composition | |
KR20170103476A (en) | Composition for prevention or treatment of oral disease comprising ROSAE LAEVIGATAE Extract | |
KR102509579B1 (en) | Oral composition comprising cassava extract | |
JP2005531556A (en) | Composition for promoting oral hygiene | |
KR102597684B1 (en) | Oral composition comprising amaranth extract | |
KR100387091B1 (en) | Composition for enhancing oral hygiene containing extract of safflower seed | |
KR101344803B1 (en) | Oral care composition comprising extract of machilus thunbergii and sequestering agent | |
KR20170125750A (en) | Oral composition | |
JPS6388117A (en) | Composition for oral cavity | |
KR20120112929A (en) | Oral composition comprising rhus verniciflua extracts and hinokitiol | |
KR20170037231A (en) | Oral composition comprising purslane extract | |
KR0138248B1 (en) | The oral cavity hygienic compositions | |
KR102597685B1 (en) | Oral composition comprising parsley extract | |
JP2004002268A (en) | Collagenase inhibitor and its utilization | |
CN114469761A (en) | Oral care compositions and methods of use and preparation thereof | |
KR100843845B1 (en) | Composition for enhancing oral health containing xanthorrhizol |